Spironolactone to improve exercise tolerance in people with permanent atrial fibrillation and preserved ejection fraction: the IMPRESS-AF RCT
Introduction: Patients with atrial fibrillation frequently suffer from heart failure despite having a normal ejection fraction. There is no proven therapy to improve physical capacity and quality of life in patients with permanent atrial fibrillation with preserved cardiac contractility. Objective:...
Main Authors: | Eduard Shantsila, Farhan Shahid, Yongzhong Sun, Jonathan J Deeks, Ronnie Haynes, Melanie Calvert, James P Fisher, Paulus Kirchhof, Paramjit S Gill, Gregory YH Lip |
---|---|
Format: | Article |
Language: | English |
Published: |
NIHR Journals Library
2020-07-01
|
Series: | Efficacy and Mechanism Evaluation |
Subjects: | |
Online Access: | https://doi.org/10.3310/eme07040 |
Similar Items
-
Outcomes of Spironolactone Withdrawal in Dilated Cardiomyopathy With Improved Ejection Fraction
by: Yanjia Chen, et al.
Published: (2021-09-01) -
Spironolactone use is associated with improved outcomes in heart failure with mid‐range ejection fraction
by: Nobuyuki Enzan, et al.
Published: (2020-02-01) -
Spotlight on Spironolactone Oral Suspension for the Treatment of Heart Failure: Focus on Patient Selection and Perspectives
by: Manolis AA, et al.
Published: (2019-12-01) -
Endothelial Progenitors and Blood Microparticles: Are They Relevant to Heart Failure With Preserved Ejection Fraction?
by: Eduard Shantsila, et al.
Published: (2016-02-01) -
Spironolactone in chronic hemodialysis patients improves cardiac function
by: Taheri Shahram, et al.
Published: (2009-01-01)